The effect of collapsing the electrochemical proton gradient (AjiH) on Erythromycin efflux studies strongly suggested that this increase was not due to an energy-dependent efflux pump but was likely due to increased outer membrane permeability. These data indicated that macrolide entry was not a AiiH-driven active transport process but rather a passive diffusion process.
Macrolide antibiotics such as erythromycin and azithromycin bind to the 50S subunit of bacterial ribosomes (22) and increase the dissociation of peptidyl-tRNA from the ribosomes (14) , thus inhibiting protein synthesis. Since the ribosome target is intracellular and macrolides must cross one (gram-positive) or two (gram-negative) membrane barriers, the mechanism of uptake into bacteria is of central importance to macrolide action on bacteria. Previous studies have demonstrated that the intracellular accumulation of erythromycin in several gram-positive organisms is unaffected by metabolic inhibitors (3, 5, 12) ; however, measurements of the proton motive force or electrochemical proton gradient (AjIH) under conditions of drug transport were not made. In addition, higher incubation temperatures and alkaline conditions tended to increase macrolide uptake and lower the MIC, thus implicating energy-independent uptake (5, 14, 20) . In contrast, macrolides concentrate severalfold in susceptible bacteria because of internal binding sites, and in some cases, resistance to macrolides is believed to involve impermeability at the level of the cell membrane (6, 11) . The latter two observations are more consistent with an active uptake process.
The outer membrane permeability barrier of gram-negative bacteria restricts the entrance of macrolide antibiotics (12, 16) . However, Haemophilus spp. are more susceptible to these antibiotics than are most gram-negative bacteria (7). The increased susceptibility of H. influenzae may be due to the lack of an 0-antigenic side chain (9) , which would increase the permeability of the outer membrane to hydrophobic agents (7, 16) . The presence of larger pores, reported to have a molecular weight exclusion limit of 1,400 (24) , may also contribute to the susceptibility differences observed.
Previous studies on the accumulation of macrolide antibiotics in gram-negative bacteria were limited to Escherichia coli, and minimum data were generated on the mechanism of transport. Triplicate 0.4-ml samples were mixed with 5 ml of cold 5% trichloroacetic acid containing 10 mg of unlabeled methionine per ml. Samples were heated at 100°C for 10 min and then cooled at 4°C. Finally, samples were collected on glass fiber filters and processed as outlined above for whole cells, except for the omission of the solubilizer. The two components of Ai\H, the proton gradient (ApH) and the AtJ, were determined by methods previously used for E. coli cells (17) . Haemophilus cells were washed with 120 mM Tris hydrochloride (pH 8.0) and then suspended either in 5 mM Tris HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) (pH 7.5) containing 150 mM choline chloride or in the wash buffer. The latter culture was treated with 1 mM EDTA at 37°C for 10 min (23). Some EDTApermeabilized cultures were also treated with the ionophore valinomycin (2 ,ug/mg of protein) during EDTA treatment (25) Aij was determined from 86Rb+ distribution in the presence of the ionophore valinomycin (1, 2 (Table 2) . Treatment with or without EDTA did not significantly alter the uptake rates for either antibiotic at 22°C (69 and 92 fmol/,ul per min, with and without EDTA, respectively, for azithromycin; 58 and 65 fmol/,l1 per min, with and without EDTA, respectively, for erythromycin). However, there was a three-to fourfold increase in rates when the macrolides were tested at 37°C after EDTA treatment. The increase in uptake rates observed at 37°C over rates observed at 22°C in untreated controls may reflect membrane b Azithromycin was tested at 0.5 pLg/ml. .5 0 E fluidity changes which allow for greater penetration of lipophilic agents (21) . The rate increases observed between the 22 and 37°C incubations of EDTA-treated cells may be due to Tris EDTA-mediated outer membrane structural damage (16) occurring at 37°C. Uptake rates increased fiveto eightfold for both macrolides at 22°C when KCl concentrations were increased to 150 mM without (0.44 pmol/,ll per min for azithromycin; 0.36 pmol/,l per min for erythromycin) or with (0.63 pmol/,ul per min for azithromycin; 0.55 pmol/,ll per min for erythromycin) CCCP pretreatment. At 37°C, uptake was so rapid that only minimum rates could be established. These data demonstrated that at 22°C, under conditions of AjiH collapse, macrolide uptake did not decrease; therefore, drug influx was not an active transport process. The increase in macrolide uptake as A,uH was reduced may indicate an energy-dependent efflux system or an increase in outer membrane permeability due to a decreased Donnan potential across this barrier (16) .
We investigated the possibility of a AjiH-driven macrolide efflux pump in H. influenzae. (Fig. 1) . The zero time for kinetic analysis was 40 min into the incubation, since this represented the first measurable time period following centrifugation and suspension (30-to 40-min time points). This processing period allowed for the decoupling effect of CCCP. The differences in initial intracellular macrolide concentrations between CCCP-treated and untreated cells at the 40-min time point may be due to cell loss during the processing period. This discrepancy was not germane to the analysis of the dissociation rate constant. The efflux of drug followed first-order kinetics for the untreated control cells with a t1/2 of 9.8 min, determined from a plot of ln (CL/CLO) versus t (Fig. 1, inset) . Similar observations were made with CCCP-treated cells for the initial 30 min (t112, 10.8 min), after which time the rate of efflux appears to decrease.
The last two time points on the efflux curve ( Fig. 1) gave measurements which were close to background and therefore not reliable for kinetic analysis. Drug efflux was also measured in EDTA-valinomycin treated cells preloaded with [3H]erythromycin, as described above (Fig. 2) . Because of the permeabilized outer membrane caused by EDTA treatment, the efflux rates were higher than in intact cells; however, the efflux of drug still followed first-order kinetics, with t1,2s of 5.1 and 4.6 min for cells in 1 and 150 mM KCl, respectively (Fig. 2, inset) . The t112 data for the EDTAvalinomycin-treated cells approach values observed in ribosome-binding studies (R. Goldman, unpublished data). Although our observations did not detect a macrolide efflux pump in this organism, we cannot rule out the existence of an inefficient efflux system masked by the ribosome binding off rate. There have been efflux pumps detected in E. coli for tetracycline (13) and norfloxacin (4), but as yet there are no published data for macrolides.
In summary, the driving force for the accumulation of erythromycin and azithromycin into H. influenzae was not dependent upon A/iH but, rather, was dependent on intra-cellular binding to ribosomes. Therefore, macrolide transport into this organism was by a passive process. Since an energy-dependent macrolide efflux pump was not detected, the increase observed in antibiotic uptake under conditions of depressed A,uH was likely the result of increased outer membrane permeability. The inhibition of protein synthesis paralleled macrolide uptake, confirming drug entry into these cells.
